source
- Curium gains FDA nod for Bexlutry as it eyes challenge to Novartis radioligand therapiesCurium recently received FDA approval for its radiopharmaceutical Bexlutry, positioning it as a direct competitor to Novartis’ Lutathera. The biotech is also in discussions with the FDA about fili…
- Beam Therapeutics sues YolTech and Serapha Bio over alleged theft of base editing trade secretsBeam Therapeutics has filed a lawsuit in U.S. District Court in Massachusetts accusing Chinese biotech YolTech Therapeutics and its U.S. partner Serapha Bio of using confidential information to dev…